● Recruiting

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

Condition: Squamous Cell Cancer of Head and Neck (SCCHN) · Sponsor: Sun Yat-sen University

PhasePhase 3

Planned participants386

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

The main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma

This description comes directly from the study's public registry record.

Talk to the study team

Lei Chen, M.D · +862013570051477 · chenlei@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (7)

Sun Yat-sen University Cancer Center	Guangzhou, Guangdong, China	Recruiting
Sun Yat-sen University Cancer Center	Guangzhou, Guangdong, China	Recruiting
Affiliated Hospital of Guilin Medical College	Guilin, Guangxi, China	Recruiting
Hainan General Hospital	Sanya, Hainan, China	Recruiting
Hunan Cancer Hospital	Changsha, Hunan, China	Recruiting
Xiangya Hospital, Central South University	Changsha, Hunan, China	Recruiting
Jiangsu Cancer Hospital	Nanjing, Jiangsu, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07125755